Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1999
06/01/1999US5908923 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection
06/01/1999US5908869 Propofol compositions containing edetate
06/01/1999US5908868 Retinol derivatives useful for enhancing immune response
06/01/1999US5908866 Pharmaceutical composition containing carbachol and other cholinergic substances
06/01/1999US5908865 Chlorhexidine gluconate-containing, stabilized aqueous pharmaceutical preparations
06/01/1999US5908864 Creatine gel
06/01/1999US5908863 Geminal carboxylic acids and esters thereof pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism
06/01/1999US5908862 Diacetyltartaric acid esters of mono- and diglycerides
06/01/1999US5908861 Poly(adp-ribose) polymerase
06/01/1999US5908860 4-carbonylamino-substituted-2,2-dimethyl-3,4-dihydrobenzopyran -3-ols
06/01/1999US5908859 Especially hypercholesterolemia
06/01/1999US5908858 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses
06/01/1999US5908857 aconite-alkaloids, aconite tuber and an extract thereof, gingerol and analogues thereof, and rhizomes of ginger; PLANT EXTRACTs; virus infections, fungal infections, opportunistic infections
06/01/1999US5908855 Administering fluconazole with a potentiator (especially procodazole). treatment of influenza.
06/01/1999US5908853 Therapy for sexual disorders
06/01/1999US5908851 Derivatives of succinamide and their use as metalloproteinase inhibitor
06/01/1999US5908850 or salts thereof, free of L-threo methylphenidate; specific entaniomer used reduces side effects including potential for drug abuse
06/01/1999US5908849 Anti-oxidant esters of non-steroidal anti-inflammatory agents
06/01/1999US5908848 Analgesics
06/01/1999US5908847 The new combination confers a synergistic effect, and provides unexpected efficacy
06/01/1999US5908846 Topical compositions for transdermal delivery of prodrug derivatives of morphine
06/01/1999US5908845 Polyether nucleic acids
06/01/1999US5908844 Neuroleptic agent
06/01/1999US5908843 Thrombosis, antiinflammatory agent, arteriosclerosis, antitumor agents
06/01/1999US5908841 5,11-dihydro-6H-dipyrido 3,2-b:2',3'-e!azepine-6-ones and their use in the prevention of treatment of HIV infection
06/01/1999US5908839 Administering mixture of tyrosine kinase inhibitor and amino sterol
06/01/1999US5908838 Method for the treatment of acne
06/01/1999US5908837 Antiinflammatory agent
06/01/1999US5908836 Administering sucrose octasulfate complex or salt; antiinflammatory, antiallergen, and wound healing agents; ultraviolet radiation resistance
06/01/1999US5908835 Anti-tumor compositions containing taxane derivatives
06/01/1999US5908834 Adding partricin a and/or partricin b derivatives to cell or tissue cultures for preventing or treating contamination of the culture by a fungal agent
06/01/1999US5908833 Glucocorticosteroid chemically bound to a sugar
06/01/1999US5908830 Combination therapy for the treatment of diabetes and obesity
06/01/1999US5908780 Cells transformed or transfected with HCMV US2 gene
06/01/1999US5908742 Synthetic media for blood components
06/01/1999US5908697 Active principle carriers containing non-ionic surfactants, and uses thereof, particularly in food, cosmetics and pharmaceuticals
06/01/1999US5908639 Inhalation powder containing antistatic agent
06/01/1999US5908638 Pharmaceutical compositions of conjugated estrogens and methods for their use
06/01/1999US5908637 Transmucosal delivery system
06/01/1999US5908636 Polyalkylene glycol having an average molecular weight of about 400 to about 20,000
06/01/1999US5908622 Food product containing thraustochytrium and/or schizochytrium microflora and an additional agricultural based ingredient
06/01/1999US5908611 Administering weak organic acid and pharmacological agent using inhalant or propellant
06/01/1999CA2255325A1 Aldehyde oxidase inhibitors for treatment of aids
06/01/1999CA2253700A1 The production of solid dosage forms
06/01/1999CA2251260A1 Escape mutant of the surface antigen of hepatitis b virus
06/01/1999CA2227403A1 Oral nicotine composition and methods
06/01/1999CA2144127C Antiageing and antistaining composition for skin and use thereof
06/01/1999CA2142314C Method of reducing blood levels of total cholesterol and low-density lipoprotein cholesterol
06/01/1999CA2141372C Stabilized cosmetic or dermatological composition containing several precursors of the same active ingredient, maximizing its release and its use
06/01/1999CA2094266C Aerosol formulations of beclomethasone-17,21-dipropionate
06/01/1999CA2056334C Process for producing benzylphthalazinone derivatives and salts thereof
06/01/1999CA2046364C Galenic process for omeprazole containing pellets
06/01/1999CA1340570C Process for synthesizing n-alkylated amino-acides and the esters thereof. their use for synthesizing carboxyalkyl dipeptides
06/01/1999CA1340567C Heterocyclic amide derivatives
05/1999
05/28/1999CA2228170A1 1-deoxy-d-xylulose 5-phosphate synthase, a process for identifying effectors of 1-deoxy-d-xylulose 5-phosphate synthase and effectors of 1-deoxy-d-xylulose 5-phosphate synthase
05/27/1999WO1999026068A1 A method and device for preventing immunoglobulin degradation in external secretions
05/27/1999WO1999025860A1 Vector for tissue-specific replication and gene expression
05/27/1999WO1999025858A1 Alphavirus vectors for paramyxovirus vaccines
05/27/1999WO1999025829A2 Cdk2 protein and cdk2 protein complexes
05/27/1999WO1999025819A2 Antisense oligonucleotides against tenascin for treating vitiligo
05/27/1999WO1999025815A2 Nucleic acids involved in the responder phenotype and applications thereof
05/27/1999WO1999025725A1 NOVEL 19-NOR STEROIDS SUBSTITUTED IN POSITION 11β, PREPARATION METHOD AND INTERMEDIATES, APPLICATION AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
05/27/1999WO1999025723A1 Chemical synthesis of 6-o-alkyl erythromycin a
05/27/1999WO1999025722A1 Process for n-desmethylating erythromycins and derivatives thereof
05/27/1999WO1999025720A1 Carbohydrate derivatives
05/27/1999WO1999025718A1 5H-PYRANO[2,3-d:6,5-d']DIPYRIMIDINE DERIVATIVES HAVING AN ANTIBACTERIAL, ANTIVIRAL AND IMMUNO-MODULATING ACTIVITY
05/27/1999WO1999025716A2 Pyranones, method for the production and use thereof
05/27/1999WO1999025715A1 Preparation of terazosin hydrochloride dihydrate
05/27/1999WO1999025714A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
05/27/1999WO1999025711A1 New process
05/27/1999WO1999025710A1 Imidazole derivatives, preparation and therapeutic application thereof
05/27/1999WO1999025709A1 Isoquinoline derivatives and their therapeutical use
05/27/1999WO1999025707A1 2-ARYLBENZO[b]THIOPHENES USEFUL FOR THE TREATMENT OF ESTROGEN DEPRIVATION SYNDROME
05/27/1999WO1999025706A1 2-aryl-3-aroylbenzo[b]thiophenes useful for the treatment of estrogen deprivation syndrome
05/27/1999WO1999025705A1 Recovery of taxanes from plant material
05/27/1999WO1999025701A1 NOVEL HETEROCYCLICALLY SUBSTITUTED α-HYDROXYCARBOXLIC ACID DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS
05/27/1999WO1999025699A1 Salts of 5,5'-arylidenebisbarbituric and 5,5'-arylidenebis(2-thiobarbituric) acids and 5,5'-arylidenebis(2-thiobarbituric) acids having an antibacterial, anti-chlamydial, antiviral and immuno-modulating activity
05/27/1999WO1999025697A1 Novel pyridazine derivatives and drugs containing the same as the active ingredient
05/27/1999WO1999025695A1 5-arylpyrazole compounds
05/27/1999WO1999025693A1 Metalloproteinase inhibitors
05/27/1999WO1999025690A2 Advanced glycation end-product intermediaries and post-amadori inhibition
05/27/1999WO1999025688A1 Process for the preparation of 1,4-dihydropyridines and compounds used in this process
05/27/1999WO1999025687A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
05/27/1999WO1999025686A1 Cyclic amine derivatives and their use as drugs
05/27/1999WO1999025683A1 Position-4 substituted 2-pyrrolidinone derivatives to reduce the level of extracellular glutamate
05/27/1999WO1999025382A1 Pharmaceutical combination of a cyclooxygenase-2 inhibitor
05/27/1999WO1999025374A1 Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders
05/27/1999WO1999025365A1 Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis
05/27/1999WO1999025364A1 Method for treating attention deficit disorder
05/27/1999WO1999025363A1 Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia
05/27/1999WO1999025362A1 Use of mixtures of active agents containing phytostenol for producing hypocholesteraemic preparations
05/27/1999WO1999025361A1 Use of selected phytostenol esters for producing hypocholesteraemic preparations
05/27/1999WO1999025360A2 Progestogen-antiprogestogen regimens
05/27/1999WO1999025359A1 New composition of matter
05/27/1999WO1999025358A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
05/27/1999WO1999025357A1 USE OF 9-DEOXY-2', 9-α-METHANO-3- OXA-4,5,6- TRINOR-3, 7-(1',3'-INTERPHENYLENE) -13,14-DIHYDRO- PROSTAGLANDIN F1 TO TREAT PERIPHERAL VASCULAR DISEASE
05/27/1999WO1999025356A1 Use of mirtazapine for treating sleep apneas
05/27/1999WO1999025355A1 Method of treating addiction to nicotine products
05/27/1999WO1999025354A2 Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters
05/27/1999WO1999025353A1 Therapeutic uses of triazolo-pyridazine derivatives
1 ... 6494 6495 6496 6497 6498 6499 6500 6501 6502 6503 6504 6505 6506 6507 6508 6509 6510 6511 6512 6513 6514 ... 7860